Amplify Weight Loss Drug & Treatment ETF (THNR)
NYSEARCA: THNR · Real-Time Price · USD
22.56
+0.11 (0.50%)
Aug 1, 2025, 4:00 PM - Market closed
THNR Holdings Information
THNR is an equity ETF with a total of 22 individual holdings. The top holdings are Eli Lilly and Company stock at 12.23%, Novo Nordisk at 8.05%, Regeneron Pharmaceuticals at 7.38%, Amgen at 7.05%, and Chugai Pharmaceutical at 6.65%.
Total Holdings
22
Top 10 Percentage
67.41%
Asset Class
Equity
ETF Category
Health
Assets
3.00M
PE Ratio
19.25
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 12.23% |
| 2 | NVO | Novo Nordisk A/S | 8.05% |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 7.38% |
| 4 | AMGN | Amgen Inc. | 7.05% |
| 5 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 6.65% |
| 6 | GILD | Gilead Sciences, Inc. | 5.34% |
| 7 | AZN | AstraZeneca PLC | 5.33% |
| 8 | MRK | Merck & Co., Inc. | 5.21% |
| 9 | ABBV | AbbVie Inc. | 5.13% |
| 10 | HKG: 1801 | Innovent Biologics, Inc. | 5.03% |
| 11 | PFE | Pfizer Inc. | 5.00% |
| 12 | SWX: ROG | Roche Holding AG | 4.98% |
| 13 | HIMS | Hims & Hers Health, Inc. | 4.83% |
| 14 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 4.73% |
| 15 | TYO: 4507 | Shionogi & Co., Ltd. | 4.20% |
| 16 | VKTX | Viking Therapeutics, Inc. | 2.40% |
| 17 | CPH: ZEAL | Zealand Pharma A/S | 2.18% |
| 18 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.66% |
| 19 | HKG: 3933 | The United Laboratories International Holdings Limited | 1.17% |
| 20 | KRX: 128940 | Hanmi Pharm. Co., Ltd. | 0.82% |
| 21 | AGPXX | Short-Term Investment Trust - Invesco Government & Agency Portfolio | 0.37% |
| 22 | n/a | DEPOSITS WITH BROKER FOR SHORT POSITIONS | 0.24% |
As of Jul 30, 2025